Enterprise Solutions

INSIGHTS ON ENTERPRISE SOLUTIONS

Samsung Biologics Capabilities Update June 2026: ADC
Explore how our integrated bioconjugation platform and expanded capabilities can help advance the development and scalable manufacturing of next-generation therapeutics.
FUJIFILM Biotechnologies June 2026 Capabilities Update: Microbial Development & Mfg
Explore FUJIFILM Biotechnologies’ process development capabilities that make reaching IND quickly a reality, while our experts work with you to create flexible approaches to BLA.
WuXi Biologics June 2026 Capabilities Update: Cell Line Development
Targeted integration improves titer, stability, and consistency in cell line development, accelerating timelines, reducing risk, and enabling scalable, data-driven CMC for complex biologics.
Rentschler Biopharma June 2026 Capabilities Update: Cell Line Development
Next-gen CMC uses high-performing cell lines to accelerate timelines, improve consistency, and scale efficiently, leveraging gains in stability, pool quality, and process intensification.

Structuring ADC Analytical Partnerships From Pre-IND To Commercial
6/17/2026

ADC success depends less on molecular design than on a continuous analytical strategy that connects early characterization to late-stage control, preventing variability, data gaps, and regulatory issues from compounding over time.
Accelerating Biologics With Seamless Technology Transfer
6/17/2026

Discover how effective technology transfer strategies can streamline scale-up, maintain product quality, and enable successful clinical and commercial manufacturing.
Simplifying ADC Development Through CDMO Collaboration
6/17/2026

Two CDMOs are working together to simplify ADC development. Learn how integrated support and collaboration can reduce complexity, streamline transfers, and keep programs moving forward.
BIOSECURE, Tariffs, And The New CDMO Reality For Biopharma Innovators
6/16/2026

Secure domestic or diversified biopharma manufacturing to protect therapeutic development from supply chain disruptions, rising costs, and legislative tariff impacts.

Achieving Scale And Compliance In cGMP Cell Banking

Establish robust Master and Working Cell Banks to ensure long-term quality. Review this resource to explore specialized, compliant workflows that streamline cell expansion and safety characterization.
Ensuring Safety And Efficacy In In-Vivo CAR-T Therapies

Optimize in-vivo lentiviral CAR-T development with rigorous, GMP-compliant testing. Explore customizable assay panels designed to ensure product safety, accurate dosing, and regulatory alignment.
EZ BioPac: 8 Advantages, One Smart Solution

Learn about wide-opening single-use powder transfer bags that can cut fill times by 71% and discharge times by 18% compared to traditional narrow-neck designs.
Biologic Development, Manufacturing: Solutions For Speed, Flexibility

Your large molecule therapy has the potential to transform patient care, but in an industry where speed and precision are critical, success depends on having a trusted, fully integrated partner to guide you from development through commercialization.
PatroLab™ A Digital Platform That Monitors, Predicts, And Controls Bioprocesses

Real-time monitoring, predictive modeling, and unified data detect variability sooner, improve collaboration, and drive consistent biologics performance from development through commercial production.